This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1690 p4; 803300781
Reference
Government of Canada. Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids. Internet Document : 15 Mar 2018. Available from: URL: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66210a-eng.php
Rights and permissions
About this article
Cite this article
Health Canada to start review of ulipristal after liver disorders. Reactions Weekly 1695, 1 (2018). https://doi.org/10.1007/s40278-018-43829-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43829-2